^
Association details:
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Title:

Circulating Levels of the Interferon-?-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy

Published date:
06/07/2021
Excerpt:
In conclusion, high plasma HGF, CXCL11, CXCL10 and IL-6 levels are associated with worse outcome in mRCC patients treated with sunitinib or pazopanib.
DOI:
10.3390/cancers13112849